nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0262	0.0262	CcSEcCtD
Temozolomide—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.025	0.025	CcSEcCtD
Temozolomide—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.021	0.021	CcSEcCtD
Temozolomide—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0208	0.0208	CcSEcCtD
Temozolomide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0193	CcSEcCtD
Temozolomide—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0169	CcSEcCtD
Temozolomide—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0167	CcSEcCtD
Temozolomide—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Temozolomide—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.016	0.016	CcSEcCtD
Temozolomide—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Temozolomide—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Temozolomide—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0157	CcSEcCtD
Temozolomide—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0155	CcSEcCtD
Temozolomide—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0147	CcSEcCtD
Temozolomide—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Temozolomide—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0142	CcSEcCtD
Temozolomide—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Temozolomide—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Temozolomide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Temozolomide—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Temozolomide—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Temozolomide—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Temozolomide—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0129	CcSEcCtD
Temozolomide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Temozolomide—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Temozolomide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Temozolomide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Temozolomide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Temozolomide—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Temozolomide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Temozolomide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Temozolomide—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Temozolomide—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Temozolomide—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Temozolomide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Temozolomide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Temozolomide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Temozolomide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Temozolomide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00996	0.00996	CcSEcCtD
Temozolomide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00977	0.00977	CcSEcCtD
Temozolomide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00964	0.00964	CcSEcCtD
Temozolomide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00959	0.00959	CcSEcCtD
Temozolomide—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00913	0.00913	CcSEcCtD
Temozolomide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.009	0.009	CcSEcCtD
Temozolomide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00881	CcSEcCtD
Temozolomide—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0087	0.0087	CcSEcCtD
Temozolomide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00848	0.00848	CcSEcCtD
Temozolomide—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00843	0.00843	CcSEcCtD
Temozolomide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00835	0.00835	CcSEcCtD
Temozolomide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00832	CcSEcCtD
Temozolomide—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00827	0.00827	CcSEcCtD
Temozolomide—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00822	0.00822	CcSEcCtD
Temozolomide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00811	0.00811	CcSEcCtD
Temozolomide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00808	CcSEcCtD
Temozolomide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00805	0.00805	CcSEcCtD
Temozolomide—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00795	0.00795	CcSEcCtD
Temozolomide—Cough—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00785	CcSEcCtD
Temozolomide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00766	0.00766	CcSEcCtD
Temozolomide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00766	0.00766	CcSEcCtD
Temozolomide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00763	CcSEcCtD
Temozolomide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00757	0.00757	CcSEcCtD
Temozolomide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00749	CcSEcCtD
Temozolomide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0074	CcSEcCtD
Temozolomide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00734	0.00734	CcSEcCtD
Temozolomide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00734	0.00734	CcSEcCtD
Temozolomide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00719	0.00719	CcSEcCtD
Temozolomide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0071	0.0071	CcSEcCtD
Temozolomide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.007	0.007	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00669	0.00669	CcSEcCtD
Temozolomide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00664	0.00664	CcSEcCtD
Temozolomide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00659	0.00659	CcSEcCtD
Temozolomide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00655	0.00655	CcSEcCtD
Temozolomide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00653	0.00653	CcSEcCtD
Temozolomide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00646	CcSEcCtD
Temozolomide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00638	0.00638	CcSEcCtD
Temozolomide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00633	CcSEcCtD
Temozolomide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00628	CcSEcCtD
Temozolomide—Pain—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00628	CcSEcCtD
Temozolomide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00605	0.00605	CcSEcCtD
Temozolomide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.006	0.006	CcSEcCtD
Temozolomide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00583	CcSEcCtD
Temozolomide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00581	CcSEcCtD
Temozolomide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00581	CcSEcCtD
Temozolomide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00541	CcSEcCtD
Temozolomide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00527	CcSEcCtD
Temozolomide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0052	0.0052	CcSEcCtD
Temozolomide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00502	0.00502	CcSEcCtD
Temozolomide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00486	0.00486	CcSEcCtD
Temozolomide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00467	CcSEcCtD
Temozolomide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Temozolomide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Temozolomide—Headache—Hydrochlorothiazide—nephrolithiasis	0.0046	0.0046	CcSEcCtD
Temozolomide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00436	CcSEcCtD
